Period of time: 2014年4期
Publisher: Informa Healthcare
Founded in: 2005
Total resources: 64
ISSN: 1742-5255
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4
Menu
Methods for pharmacokinetic analysis in young children
By Himebauch Adam S,Zuppa Athena in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Xenobiotic effects in the ovary: temporary versus permanent infertility
By Hoyer Patricia B,Keating Aileen F in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers
By Höcht Christian,Bertera Facundo Martín,Del Mauro Julieta Sofía,Taira Carlos Alberto in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.By Wan Xiao Chloe,Dimov Vesselin in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Mathematical models for skin toxicology
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Clinically relevant drug–drug interactions between antiretrovirals and antifungals
By Vadlapatla Ramya Krishna,Patel Mitesh,Paturi Durga K,Pal Dhananjay,Mitra Ashim K in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.By de Lima Toccafondo Vieira Manuela,Tagliati Carlos Alberto in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes
By Stein Stephanie A,Lamos Elizabeth M,Davis Stephen N in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction
By Coons James C,Schwier Nicholas,Harris Justin,Seybert Amy L in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
By Tanasescu Radu,Constantinescu Cris S in (2014)
Expert Opinion on Drug Metabolism and Toxicology,volume 10,issue 4 , Vol. 10, Iss. 4, 2014-04 , pp.